retatrutide weight loss phase 2 trial of for Obesity VisualAbstract: Retatrutide reduces body weight

For ongoing obesity management, patients should discuss alternative options with their GP or specialist, which may include other pharmacological agents (such as orlistat), behavioural interventions, or referral for bariatric surgery assessment in appropriate cases

M., ONeil, C

Diabetes Ther 11(5):10611075

Additionally, Farxiga was among the medications selected for Medicare price negotiations under the Inflation Reduction Act, with the negotiated price set to take effect in 2026

While the powder required an occasional extra shake to redistribute the vanilla beans, this was a minor inconvenience given the overall quality of the product

This weight loss is not merely an aesthetic benefit